Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat
Status:
Completed
Trial end date:
2017-06-02
Target enrollment:
Participant gender:
Summary
Study LIPO-202-CL-31 is a multi center, randomized, double-blind, placebo-controlled study to
evaluate the safety and efficacy of two different doses of LIPO-202 versus placebo on
submental bulging due to subcutaneous fat. Approximately 150 participants of either gender
who have a "Moderate Bulge" or "Large Bulge" in the submental fat (on Patient-Reported
Submental Bulging Scale [PR-SBS] and Clinician-Reported Submental Bulging Scale [CR-SBS])
will be recruited for this study.